Researchers performed a comprehensive evaluation of metabolic adaptation to tyrosine kinase inhibitor treatment and its role in chronic myelogenous leukemia hematopoietic stem and progenitor cell persistence.
[Blood]
Home Newsletters Cancer Stem Cell News Metabolic Adaptation to Tyrosine Kinase Inhibition in Leukemia Stem Cells
